Loading...
Mind Medicine (MindMed) Inc.
MMED.NE•NEO
HealthcareBiotechnology
CA$14.90
CA$1.29(9.48%)
Mind Medicine (MindMed) Inc. (MMED.NE) Financial Performance & Statements
Review Mind Medicine (MindMed) Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
-10.71%
↓ 10.71%
Net Income Growth
-13.52%
↓ 13.52%
Operating Cash Flow Growth
-22.94%
↓ 22.94%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-33.44%
↓ 33.44%
ROIC
-46.51%
↓ 46.51%
Mind Medicine (MindMed) Inc. (MMED.NE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Mind Medicine (MindMed) Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $527000.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$527000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | ||
| R&D Expenses | $21.76M | $17.19M | $14.64M | $11.18M |
| SG&A Expenses | $10.70M | $7.60M | $9.81M | $10.50M |
| Operating Expenses | $32.46M | $24.79M | $24.46M | $21.68M |
| Total Costs & Expenses | $32.46M | $24.79M | $24.46M | $22.20M |
| Interest Income | $3.28M | $3.51M | $3.12M | $1.66M |
| Interest Expense | $656000.00 | $727000.00 | $466000.00 | $434000.00 |
| Depreciation & Amortization | $0.00 | $11.84M | $0.00 | $527000.00 |
| EBITDA | -$34.09M | -$12.96M | -$5.39M | -$53.44M |
| EBITDA Ratio | ||||
| Operating Income | -$32.46M | -$24.79M | -$24.46M | -$22.20M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$2.28M | $11.11M | $18.60M | -$32.20M |
| Income Before Tax | -$34.74M | -$13.68M | -$5.85M | -$54.40M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $483724.00 |
| Net Income | -$34.74M | -$13.68M | -$5.85M | -$54.40M |
| Net Income Ratio | ||||
| EPS | -$0.41 | -$0.18 | -$0.08 | -$1.14 |
| Diluted EPS | -$0.41 | -$0.17 | -$0.08 | -$1.14 |
| Weighted Avg Shares Outstanding | $83.93M | $77.91M | $71.91M | $47.86M |
| Weighted Avg Shares Outstanding (Diluted) | $83.93M | $80.24M | $71.91M | $47.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan